Foot-and-mouth disease virus VP1 protein fused with cholera toxin B subunit expressed in Chlamydomonas reinhardtii chloroplast

A Chlamydomonas reinhardtii chloroplast expression vector, pACTBVP1, containing the fusion of the foot and mouth disease virus (FMDV) VP1 gene and the cholera toxin B subunit (CTB) gene was constructed and transfered to the chloroplast genome of C. reinhardtii by the biolistic method. The transformants were identified by PCR, Southern blot, Western blot and ELISA assays after selection on resistant medium and incubation in the dark. The CTBVP1 fusion protein was expressed in C. reinhardtii chloroplast and accounted for up to 3% of the total soluble protein. The fusion protein also retained both GM1-ganglioside binding affinity and antigenicity of the FMDV VP1 and CTB proteins. These experimental results support the possibility of using transgenic chloroplasts of green alga as a mucosal vaccine source.

[1]  Elizabeth H. Harris,et al.  The Chlamydomonas Sourcebook: A Comprehensive Guide to Biology and Laboratory Use , 1989 .

[2]  M. Goldschmidt-Clermont,et al.  Transgenic expression of aminoglycoside adenine transferase in the chloroplast: a selectable marker of site-directed transformation of chlamydomonas. , 1991, Nucleic acids research.

[3]  I. Charles,et al.  Intranasal immunization using the B subunit of the Escherichia coli heat‐labile toxin fused to an epitope of the Bordetella pertussis P.69 antigen , 1991, Molecular microbiology.

[4]  K. Richards,et al.  Engineering the chloroplast genome: techniques and capabilities for chloroplast transformation in Chlamydomonas reinhardtii. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[5]  F. Brown.  New approaches to vaccination against foot-and-mouth disease. , 1992, Vaccine.

[6]  J. Suzuki,et al.  Light-independent chlorophyll biosynthesis: involvement of the chloroplast gene chlL (frxC). , 1992, The Plant cell.

[7]  J. Erickson.  Chloroplast Transformation: Current Results and Future Prospects , 1996 .

[8]  J. Oliveros,et al.  Protective Immune Response to Foot-and-Mouth Disease Virus with VP1 Expressed in Transgenic Plants , 1998, Journal of Virology.

[9]  Guo-Hong Fan,et al.  Establishment ofChlamydomonas reinhardtii chloroplast expression , 1999 .

[10]  J. Jia,et al.  Cloning and characterization of a C genome-specific repetitive sequence inAegilops caudata L. , 1999 .

[11]  J. Escribano,et al.  Induction of a protective antibody response to foot and mouth disease virus in mice following oral or parenteral immunization with alfalfa transgenic plants expressing the viral structural protein VP1. , 1999, Virology.

[12]  J. A. Carroll,et al.  High-yield production of a human therapeutic protein in tobacco chloroplasts , 2000, Nature Biotechnology.

[13]  F. Sobrino,et al.  Foot-and-mouth disease virus: a long known virus, but a current threat. , 2001, Veterinary research.

[14]  Seung-Bum Lee,et al.  Expression of the native cholera toxin B subunit gene and assembly as functional oligomers in transgenic tobacco chloroplasts , 2001, Journal of Molecular Biology.

[15]  F. Smith,et al.  Expression of an antimicrobial peptide via the chloroplast genome to control phytopathogenic bacteria and fungi. , 2001, Plant physiology.

[16]  P. Maliga,et al.  Engineering the plastid genome of higher plants. , 2002, Current opinion in plant biology.

[17]  J. Pacheco,et al.  Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: Use in emergency outbreak response. , 2005, Vaccine.